CAS: 2225819-06-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BAY-2402234 REF: TM-T14501CAS: 2225819-06-5 | 98.90% | 170.00 €~1,606.00 € | Tue 21 Jan 25 |
 | BAY 2402234 REF: 3D-APD81906CAS: 2225819-06-5 | Min. 95% | To inquire | Mon 03 Mar 25 |
BAY-2402234
CAS:2225819-06-5
BAY-2402234: a selective DHODH inhibitor targeting myeloid cancers with low-nanomolar potency.
Formula:
C21H18ClF5N4O4
Purity:
98.90%
Color and Shape:
Solid
Molecular weight:
520.84
- Inhibitors
- Metabolism
- Dehydrogenase
- Microbiology/Virology
- See more categories
- DNA/RNA Synthesis
Ref: TM-T14501
| 1mg | 170.00 € | ||
| 2mg | 242.00 € | ||
| 5mg | 360.00 € | ||
| 10mg | 558.00 € | ||
| 25mg | 889.00 € | ||
| 50mg | 1,197.00 € | ||
| 100mg | 1,606.00 € | ||
| 1mL*10mM (DMSO) | 421.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
BAY 2402234
CAS:2225819-06-5
BAY 2402234 is a retinoic acid analog that induces apoptosis in cancer cells. This drug …
Formula:
C21H18ClF5N4O4
Purity:
Min. 95%
Molecular weight:
520.84 g/mol
Ref: 3D-APD81906
| 10mg | 1,091.00 € | ||
| 25mg | 1,779.00 € | ||
| 50mg | 2,845.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
